UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000060802
Receipt number R000069562
Scientific Title Multimodal Assessment of Non-Invasive Hemodynamic Parameters and Hematologic Indices During Autologous Blood Donation as a Controlled Human Model of Acute Hemorrhage: A Prospective Study
Date of disclosure of the study information 2026/03/02
Last modified on 2026/03/02 17:09:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective Study of Hemodynamic Changes During Autologous Blood Donation

Acronym

Hemo-ABD Study

Scientific Title

Multimodal Assessment of Non-Invasive Hemodynamic Parameters and Hematologic Indices During Autologous Blood Donation as a Controlled Human Model of Acute Hemorrhage: A Prospective Study

Scientific Title:Acronym

Hemo-ABD Study

Region

Japan


Condition

Condition

Patients undergoing autologous blood donation prior to orthognathic surgery

Classification by specialty

Anesthesiology Oral surgery Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This prospective study aims to evaluate hemodynamic changes during autologous blood donation (400 mL), which will be utilized as a controlled physiological model of acute hemorrhage.

Measurements will be obtained at three predefined time points: before donation, immediately after donation, and after fluid replacement. No modification of routine clinical management will be made for research purposes.

Hemodynamic parameters including estimated continuous cardiac output (esCCO), estimated stroke volume (esSV), perfusion index (PI), heart rate, and blood pressure will be recorded using non-invasive monitoring. In addition, continuous non-invasive arterial pressure and arterial waveform recordings will be obtained using a finger cuff device.

Small-volume blood samples will be collected through the existing donation line without additional venipuncture to measure hemoglobin and hematocrit levels. The association between hemodynamic parameters and hematologic changes will be analyzed.

This study seeks to clarify physiological circulatory responses to acute blood loss and to evaluate the clinical utility of non-invasive hemodynamic monitoring.

Basic objectives2

Others

Basic objectives -Others

This study is an exploratory observational study designed to analyze physiological changes in hemodynamic and hematologic parameters using autologous blood donation as a controlled model of acute hemorrhage. It is not intended to evaluate treatment efficacy or safety.

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase



Assessment

Primary outcomes

Change in estimated continuous cardiac output (esCCO) before donation, immediately after donation, and after fluid replacement during autologous blood donation (400 mL)

Key secondary outcomes

Changes in estimated stroke volume (esSV), perfusion index (PI), non-invasive arterial pressure and arterial waveform parameters, hemoglobin level, and hematocrit level measured at three time points (before donation, immediately after donation, and after fluid replacement)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

Autologous blood donation (400 mL), performed as part of routine clinical care, will be utilized as a controlled model of acute blood loss. The following additional assessments will be conducted for research purposes:

Non-invasive hemodynamic measurements (esCCO, esSV, PI, blood pressure, heart rate) at three time points: before donation, immediately after donation, and after fluid replacement

Continuous non-invasive arterial pressure and arterial waveform recording using a finger cuff device

Small-volume blood sampling through the existing donation line to measure hemoglobin and hematocrit levels

No modification of therapeutic management will be made for research purposes.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients aged 18 to 65 years

Scheduled for orthognathic surgery under general anesthesia

Planned preoperative autologous blood donation (up to 800 mL)

ASA physical status 1 to 2

Written informed consent obtained

Key exclusion criteria

Severe cardiovascular disease (arrhythmia, heart failure, ischemic heart disease)

Anemia (Hb < 11.0 g/dL)

Coagulation disorders or ongoing anticoagulant therapy

Severe hepatic or renal dysfunction

Regular use of medications affecting autonomic nervous function

Pregnancy or breastfeeding

Any condition deemed inappropriate by the investigator

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Keisuke
Middle name
Last name Kaneko

Organization

Nihon University School of Dentistry

Division name

Department of Anesthesiology

Zip code

101-8310

Address

1-8-13, Kanda Surugadai, Chiyoda-ku, Tokyo, Japan

TEL

03-3219-8140

Email

kaneko.keisuke@nihon-u.ac.jp


Public contact

Name of contact person

1st name Keisuke
Middle name
Last name Kaneko

Organization

Nihon University School of Dentistry

Division name

Department of Anesthesiology

Zip code

101-8310

Address

1-8-13, Kanda Surugadai, Chiyoda-ku, Tokyo, Japan

TEL

03-3219-8140

Homepage URL


Email

kaneko.keisuke@nihon-u.ac.jp


Sponsor or person

Institute

Nihon University

Institute

Department

Personal name

Keisuke Kaneko


Funding Source

Organization

Japan Society for the Promotion of Science (JSPS)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research Administration Office, Nihon University School of Dentistry

Address

1-8-13, Kanda Surugadai, Chiyoda-ku, Tokyo, Japan

Tel

03-3219-8060

Email

de.institute@nihon-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 03 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 03 Month 02 Day

Date of IRB

2025 Year 06 Month 17 Day

Anticipated trial start date

2026 Year 04 Month 01 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 03 Month 02 Day

Last modified on

2026 Year 03 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000069562